Letter to the editor on ‘cognitive behavior therapy for health anxiety: systematic review and meta-analysis of clinical efficacy and health economic outcomes’

"Letter to the editor on ‘cognitive behavior therapy for health anxiety: systematic review and meta-analysis of clinical efficacy and health economic outcomes’." Expert Review of Pharmacoeconomics & Outcomes Research, 20(6), pp. 683–684

Declaration of interest

Prof. Naomi A. Fineberg declares that in the past 3 years she has held research or networking grants from the ECNP, UK NIHR, EU H2020, MRC, University of Hertfordshire; she has accepted travel and/or hospitality expenses from the BAP, ECNP, RCPsych, CINP, International Forum of Mood and Anxiety Disorders, World Psychiatric Association, Indian Association for Biological Psychiatry, Sun; she has received payment from Taylor and Francis and Elsevier for editorial duties. In the past 3 years, she has accepted a paid speaking engagement in a webinar sponsored by Abbott. Previously, she has accepted paid speaking engagements in various industry supported symposia and has recruited patients for various industry-sponsored studies in the field of OCD treatment. She leads an NHS treatment service for OCD. She holds Board membership for various registered charities linked to OCD. She gives expert advice on psychopharmacology to the UK MHRA.

Prof. Umberto Albert declares that in the past 3 years has been a consultant and/or a speaker for Angelini, Neuraxpharm, Janssen Cilag, Lundbeck, Innova Pharma.

Prof. Keith Laws, Dr. Luca Pellegrini and Dr. Jemma Reid report no financial relationships with commercial interests.

Additional information

Funding

No funding was received for this work.